Innoviva Price to Sales Ratio 2010-2025 | INVA
Historical PS ratio values for Innoviva (INVA) over the last 10 years. The current P/S ratio for Innoviva as of June 30, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$0.953B |
$0.331B |
|
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
|
